Prevention of congenital Chagas through treatment of girls and women of childbearing age

Moscatelli, Guillermo; Moroni, Samanta; García-Bournissen, Facundo; Ballering, Griselda; Bisio, Margarita; Freilij, Héctor; Altcheh, Jaime.
Mem. Inst. Oswaldo Cruz ; 110(4): 507-509, 09/06/2015. tab
Artículo en Inglés | LILACS | ID: lil-748867

Documentos relacionados

  1. Prevention of congenital Chagas through treatment of girls and women of childbearing age.
  2. Benznidazole, itraconazole, and their combination for the treatment of chronic experimental Chagas disease in dogs.
  3. Reduced Trypanosoma cruzi-specific humoral response and enhanced T cell immunity after treatment interruption with benznidazole in chronic Chagas disease.
  4. Treatment of Infected Women of Childbearing Age Prevents Congenital Trypanosoma cruzi Infection by Eliminating the Parasitemia Detected by PCR.
  5. Ferrocene-based nitroheterocyclic sulfonylhydrazones: design, synthesis, characterization and trypanocidal properties.
  6. Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi <i>In Vitro</i> and <i>In Vivo</i>.
  7. Effect of B-NIPOx in Experimental <i>Trypanosoma cruzi</i> Infection in Mice.
  8. Frequency Variation and Dose Modification of Benznidazole Administration for the Treatment of Trypanosoma cruzi Infection in Mice, Dogs, and Nonhuman Primates.
  9. Benzonidazole treatment has a beneficial effect on cells infected with the Colombian strain of Trypanosoma cruzi.
  10. B-Cell Responses in Chronic Chagas Disease: Waning of Trypanosoma cruzi-Specific Antibody-Secreting Cells Following Successful Etiological Treatment.